Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovaries

L. Anttila, P. Koskinen, H. L. Kaihola, R. Erkkola, K. Irjala, Kristiina R Altman

Research output: Contribution to journalArticle

Abstract

Objective: To examine the effect of short-term progestogen treatment on androgen, gonadotropin, and sex hormone-binding globulin (SHBG) levels in oligomenorrheic women. Design: Comparative study of changes in hormonal parameters in patients with or without ultrasonographically diagnosed polycystic ovarian disease (PCOD). Setting: Open patient clinic of reproductive endocrinology at University Central Hospital of Turku, Finland. Patients: Seventy-five oligomenorrheic women with (n = 51) or without (n = 24) PCOD. Main Outcome Measures: Serum concentrations of testosterone (T), androstenedione (A), dehydroepiandrosterone sulfate, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and SHBG. Results: The levels of T, A, LH, and the LH:FSH ratios decreased significantly after oral treatment with medroxyprogesterone acetate (10 mg/d for 10 days) in non-PCOD women and in women with PCOD decreasing the frequencies of pathological laboratory findings, in particular elevated levels of LH:FSH ratio and A in PCOD women and of LH:FSH ratio in non-PCOD women. The levels of T, A, and LH as well as the LH:FSH ratio were significantly higher in women with PCOD. Obesity was associated with high free androgen indices, low LH:FSH ratios, and low concentrations of LH, A, and SHBG. Conclusions: The serum samples for hormonal analyses used as an aid in diagnosing PCOD should be obtained without pretreatment with progestogen because it masks the biochemical findings of PCOD.

Original languageEnglish (US)
Pages (from-to)697-702
Number of pages6
JournalFertility and Sterility
Volume58
Issue number4
StatePublished - 1992
Externally publishedYes

Fingerprint

Ovarian Diseases
Progestins
Luteinizing Hormone
Gonadotropins
Androgens
Ovary
Follicle Stimulating Hormone
Hemorrhage
Serum
Sex Hormone-Binding Globulin
Dehydroepiandrosterone Sulfate
Medroxyprogesterone Acetate
Androstenedione
Endocrinology
Finland
Masks
Testosterone
Obesity
Outcome Assessment (Health Care)

Keywords

  • androgens
  • gonadotropins
  • medroxyprogesterone acetate
  • oligomenorrhea
  • Polycystic ovarian disease

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovaries. / Anttila, L.; Koskinen, P.; Kaihola, H. L.; Erkkola, R.; Irjala, K.; Altman, Kristiina R.

In: Fertility and Sterility, Vol. 58, No. 4, 1992, p. 697-702.

Research output: Contribution to journalArticle

@article{d88bef84ce8c489f95b2414f2d7f4177,
title = "Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovaries",
abstract = "Objective: To examine the effect of short-term progestogen treatment on androgen, gonadotropin, and sex hormone-binding globulin (SHBG) levels in oligomenorrheic women. Design: Comparative study of changes in hormonal parameters in patients with or without ultrasonographically diagnosed polycystic ovarian disease (PCOD). Setting: Open patient clinic of reproductive endocrinology at University Central Hospital of Turku, Finland. Patients: Seventy-five oligomenorrheic women with (n = 51) or without (n = 24) PCOD. Main Outcome Measures: Serum concentrations of testosterone (T), androstenedione (A), dehydroepiandrosterone sulfate, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and SHBG. Results: The levels of T, A, LH, and the LH:FSH ratios decreased significantly after oral treatment with medroxyprogesterone acetate (10 mg/d for 10 days) in non-PCOD women and in women with PCOD decreasing the frequencies of pathological laboratory findings, in particular elevated levels of LH:FSH ratio and A in PCOD women and of LH:FSH ratio in non-PCOD women. The levels of T, A, and LH as well as the LH:FSH ratio were significantly higher in women with PCOD. Obesity was associated with high free androgen indices, low LH:FSH ratios, and low concentrations of LH, A, and SHBG. Conclusions: The serum samples for hormonal analyses used as an aid in diagnosing PCOD should be obtained without pretreatment with progestogen because it masks the biochemical findings of PCOD.",
keywords = "androgens, gonadotropins, medroxyprogesterone acetate, oligomenorrhea, Polycystic ovarian disease",
author = "L. Anttila and P. Koskinen and Kaihola, {H. L.} and R. Erkkola and K. Irjala and Altman, {Kristiina R}",
year = "1992",
language = "English (US)",
volume = "58",
pages = "697--702",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Serum androgen and gonadotropin levels decline after progestogen-induced withdrawal bleeding in oligomenorrheic women with or without polycystic ovaries

AU - Anttila, L.

AU - Koskinen, P.

AU - Kaihola, H. L.

AU - Erkkola, R.

AU - Irjala, K.

AU - Altman, Kristiina R

PY - 1992

Y1 - 1992

N2 - Objective: To examine the effect of short-term progestogen treatment on androgen, gonadotropin, and sex hormone-binding globulin (SHBG) levels in oligomenorrheic women. Design: Comparative study of changes in hormonal parameters in patients with or without ultrasonographically diagnosed polycystic ovarian disease (PCOD). Setting: Open patient clinic of reproductive endocrinology at University Central Hospital of Turku, Finland. Patients: Seventy-five oligomenorrheic women with (n = 51) or without (n = 24) PCOD. Main Outcome Measures: Serum concentrations of testosterone (T), androstenedione (A), dehydroepiandrosterone sulfate, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and SHBG. Results: The levels of T, A, LH, and the LH:FSH ratios decreased significantly after oral treatment with medroxyprogesterone acetate (10 mg/d for 10 days) in non-PCOD women and in women with PCOD decreasing the frequencies of pathological laboratory findings, in particular elevated levels of LH:FSH ratio and A in PCOD women and of LH:FSH ratio in non-PCOD women. The levels of T, A, and LH as well as the LH:FSH ratio were significantly higher in women with PCOD. Obesity was associated with high free androgen indices, low LH:FSH ratios, and low concentrations of LH, A, and SHBG. Conclusions: The serum samples for hormonal analyses used as an aid in diagnosing PCOD should be obtained without pretreatment with progestogen because it masks the biochemical findings of PCOD.

AB - Objective: To examine the effect of short-term progestogen treatment on androgen, gonadotropin, and sex hormone-binding globulin (SHBG) levels in oligomenorrheic women. Design: Comparative study of changes in hormonal parameters in patients with or without ultrasonographically diagnosed polycystic ovarian disease (PCOD). Setting: Open patient clinic of reproductive endocrinology at University Central Hospital of Turku, Finland. Patients: Seventy-five oligomenorrheic women with (n = 51) or without (n = 24) PCOD. Main Outcome Measures: Serum concentrations of testosterone (T), androstenedione (A), dehydroepiandrosterone sulfate, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and SHBG. Results: The levels of T, A, LH, and the LH:FSH ratios decreased significantly after oral treatment with medroxyprogesterone acetate (10 mg/d for 10 days) in non-PCOD women and in women with PCOD decreasing the frequencies of pathological laboratory findings, in particular elevated levels of LH:FSH ratio and A in PCOD women and of LH:FSH ratio in non-PCOD women. The levels of T, A, and LH as well as the LH:FSH ratio were significantly higher in women with PCOD. Obesity was associated with high free androgen indices, low LH:FSH ratios, and low concentrations of LH, A, and SHBG. Conclusions: The serum samples for hormonal analyses used as an aid in diagnosing PCOD should be obtained without pretreatment with progestogen because it masks the biochemical findings of PCOD.

KW - androgens

KW - gonadotropins

KW - medroxyprogesterone acetate

KW - oligomenorrhea

KW - Polycystic ovarian disease

UR - http://www.scopus.com/inward/record.url?scp=0026655542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026655542&partnerID=8YFLogxK

M3 - Article

C2 - 1426312

AN - SCOPUS:0026655542

VL - 58

SP - 697

EP - 702

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 4

ER -